AU2018900077A0 - Pharmaceutical composition for treatment of an eye disease or condition - Google Patents

Pharmaceutical composition for treatment of an eye disease or condition

Info

Publication number
AU2018900077A0
AU2018900077A0 AU2018900077A AU2018900077A AU2018900077A0 AU 2018900077 A0 AU2018900077 A0 AU 2018900077A0 AU 2018900077 A AU2018900077 A AU 2018900077A AU 2018900077 A AU2018900077 A AU 2018900077A AU 2018900077 A0 AU2018900077 A0 AU 2018900077A0
Authority
AU
Australia
Prior art keywords
treatment
condition
pharmaceutical composition
eye disease
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018900077A
Inventor
Philip Leslie Penfold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eye Co Pty Ltd
Original Assignee
Eye Co Pty Ltd
Filing date
Publication date
Application filed by Eye Co Pty Ltd filed Critical Eye Co Pty Ltd
Publication of AU2018900077A0 publication Critical patent/AU2018900077A0/en
Priority to US16/961,617 priority Critical patent/US11701368B2/en
Priority to EP19738897.8A priority patent/EP3737381A4/en
Priority to PCT/AU2019/000002 priority patent/WO2019136512A1/en
Priority to AU2019207515A priority patent/AU2019207515A1/en
Priority to US18/139,024 priority patent/US20230346802A1/en
Abandoned legal-status Critical Current

Links

AU2018900077A 2018-01-10 2018-01-10 Pharmaceutical composition for treatment of an eye disease or condition Abandoned AU2018900077A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US16/961,617 US11701368B2 (en) 2018-01-10 2019-01-09 Unit dose pharmaceutical of a dry powder of one or more glucocorticoid or mineralocorticoid fludrocortisone acetate and/or triamcinolone acetonide comprised in a syringe
EP19738897.8A EP3737381A4 (en) 2018-01-10 2019-01-09 Medical device and pharmaceutical composition for treatment of an eye disease or condition
PCT/AU2019/000002 WO2019136512A1 (en) 2018-01-10 2019-01-09 Medical device and pharmaceutical composition for treatment of an eye disease or condition
AU2019207515A AU2019207515A1 (en) 2018-01-10 2019-01-09 Medical device and pharmaceutical composition for treatment of an eye disease or condition
US18/139,024 US20230346802A1 (en) 2018-01-10 2023-04-25 Unit dose pharmaceutical of a dry powder of one or more glucocorticoid or mineralocorticoid fludrocortisone acetate and/or triamcinolone acetonide comprised in a syringe

Publications (1)

Publication Number Publication Date
AU2018900077A0 true AU2018900077A0 (en) 2018-01-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP3823568A4 (en) Surgical treatment for glaucoma
EP3852735A4 (en) Farnesoid x receptor agonists for the treatment of disease
EP3856478A4 (en) Formulations for treatment of dry eye disease
EP3790867A4 (en) Kdm1a inhibitors for the treatment of disease
EP3672587A4 (en) Pharmaceutical compositions for the treatment of ophthalmic conditions
IL281773A (en) Ophthalmic composition for treatment of dry eye disease
EP4021500A4 (en) Methods for the treatment of thyroid eye disease
EP3810124A4 (en) Composition for treatment of dry eye disease and meibomianitis
EP3934646A4 (en) Pharmaceutical compositions for treating ocular diseases or disorders
EP3713553A4 (en) Compositions and methods for treatment of eye diseases
EP4000609A4 (en) Pharmaceutical composition for preventing or treating bone diseases
EP3880690A4 (en) Peptides and pharmaceutical compositions for treating eye diseases
EP3902525A4 (en) Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
EP3458045A4 (en) Treatment of meniere's disease
EP3691654A4 (en) Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
EP3709982A4 (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
EP3740592A4 (en) Methods and compositions for the treatment of vascular disease
EP3730144A4 (en) Agent for treatment of nervous system disease
EP3600324A4 (en) Drugs and compositions for the treatment of ocular disorders
EP3675889A4 (en) Angio-3 for treatment of retinal angiogenic diseases
EP3737381A4 (en) Medical device and pharmaceutical composition for treatment of an eye disease or condition
EP3820477A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3777847A4 (en) Pharmaceutical composition for prevention or treatment of fibrosis
EP3632447A4 (en) Pharmaceutical composition for prevention or treatment of bone-related disease
EP3310310A4 (en) Apparatus for treatment of menière's disease